大学院医学研究院

Research Areas

Life sciences / Cardiovascular surgery /
Life sciences / Respiratory surgery /

Research History

12 >

Apr 2023

-

Today

International University of Health and Welfare Narita Hospital Hospital Director

Apr 2023

-

Today

Chiba University

2007

-

Mar 2023

Chiba University

2004

-

2007

九州大学大学院医学研究院准教授

2003

-

2004

九州大学附属病院講師

Education

Aug 1992

-

Jun 1994

Harvard University Brigham and Women's Hospitall Department of Surgery,

Aug 1992

-

Jun 1994

Harvard Medical School, Brigham and Women's Hospital

-

1992

Kyushu University

-

1992

Kyushu University

-

1987

Kyushu University School of Medicine

Committee Memberships

12 >

2002

American College of Surgeons Fellow

2002

Japan Lung Cancer Society Member of Comittee

2002

日本肺癌学会評議員

2002

米国外科学会正会員

2001

Japanese Association for Chest Surgery Member of Comittee

Papers

12 3 4 5 >

What are the risk factors for postoperative home oxygen therapy in patients with lung cancer?

Takahiro Yamanaka Yuichi Sakairi Yuki Sata Takahide Toyoda Terunaga Inage Kazuhisa Tanaka Hidemi Suzuki Yukiko Matsui Ichiro Yoshino

Journal of thoracic disease 16(2) 989-996 Feb 2024

BACKGROUND: Home oxygen therapy (HOT) is used to treat chronic respiratory diseases and is sometimes required in patients with lung cancer after radical surgery. We aimed to identify the risk factors for postoperative home-based oxygen therapy in ...

Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry Database.

Yusuke Okuma Yasushi Shintani Ikuo Sekine Takehito Shukuya Koichi Takayama Akira Inoue Isamu Okamoto Katsuyuki Kiura Nobuyuki Yamamoto Tomoya Kawaguchi Etsuo Miyaoka Ichiro Yoshino Hiroshi Date

Clinical lung cancer Feb 2024

BACKGROUND: In advanced non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations, those with impaired performance status (PS) treated with EGFR-tyrosine kinase inhibitors (TKIs) have demonstrated comp...

Long-term nintedanib treatment for progressive pulmonary fibrosis associated with Hermansky-Pudlak syndrome type 1 followed by lung transplantation.

Taku Itoh Takeshi Kawasaki Taisuke Kaiho Kohei Shikano Akira Naito Mitsuhiro Abe Hidemi Suzuki Masayuki Ota Ichiro Yoshino Takuji Suzuki

Respiratory investigation 62(1) 176-178 Dec 2023

Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disease that often causes progressive pulmonary fibrosis (HPS-PPF) in some genetic types with high mortality rates. No effective treatment for HPS-PPF other than lung transplantation ha...

Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer.

Teruaki Mizobuchi Akihiro Nomoto Hironobu Wada Naoyoshi Yamamoto Mio Nakajima Takehiko Fujisawa Hidemi Suzuki Ichiro Yoshino

Radiation oncology (London, England) 18(1) 201-201 Dec 2023

PURPOSE: This study aimed to compare the outcomes of patients with ground-grass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) who were treated with carbon ion radiotherapy (CIRT) versus segmentectomy. METHODS: A retrospective review of...

Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.

Seiki Hasegawa Yasushi Shintani Teruhisa Takuwa Keisuke Aoe Katsuya Kato Nobukazu Fujimoto Yasuhiro Hida Masahiro Morise Yasumitsu Moriya Takao Morohoshi Hidemi Suzuki Masayuki Chida Shunsuke Endo Mitsutaka Kadokura Meinoshin Okumura Satoshi Hattori Hiroshi Date Ichiro Yoshino

Cancer science Dec 2023

Due to the scarcity of large-sized prospective databases, the Japanese Joint Committee for Lung Cancer Registry conducted a nationwide prospective registry for newly diagnosed and untreated pleural mesothelioma. All new cases diagnosed pathologica...